Ci Medical Technologies Sold to Technimark

New York, NY: Altaris Capital Partners, LLC is pleased to announce that Ci Medical Technologies has been sold to Technimark.
Ci Medical Technologies is a manufacturer of injection-molded plastic components for precision medical devices. The company provides its blue-chip OEM customers with design, prototyping, assembly, packaging and distribution services through its manufacturing facilities in North America and Europe. Altaris acquired Ci Medical Technologies in 2006 and, during its investment period, supported the company as it expanded its capabilities, service offerings and geographic footprint to better serve its customers worldwide.
Ci Medical Technologies and Altaris Capital Partners were advised on this transaction by Lincoln International LLC and Schiff Hardin LLP.
About Altaris Capital Partners, LLC
Altaris Capital Partners, LLC is an investment firm focused exclusively on the healthcare industry. Managing $1.3 billion of equity capital, Altaris invests in businesses that meet clearly defined healthcare needs and leverages its extensive industry knowledge and relationships to accelerate growth and value appreciation. Altaris is based in New York, NY.
About Ci Medical Technologies
Ci Medical Technologies is a full-service contract manufacturer of injection-molded components used in medical devices and pharmaceutical products. The company’s production facilities are located in Latrobe, Pennsylvania; El Paso, Texas; Ponce, Puerto Rico; and Durham, U.K.; and its third-party logistics facility is in Ciudad Juarez, Mexico. Ci Medical Technologies’ operations meet all applicable ANSI and ISO standards, and FDA regulations, and reflect the best practices of Lean Six Sigma management. Ci Medical Technologies was founded in 1971 and is headquartered in Latrobe, PA.